News

The FDA has approved GSK’s myelofibrosis drug, as well as a new indication for Jardiance and a new dosing regimen for Talicia. The agency has also issued a complete response letter for epinephrine nasal spray and assigned a review date for the gene therapy atidarsagene autotemcel.

An analysis by 3 Axis Advisors has found that there is a large variability in pharmacy reimbursement of prescription drugs depending on PBM contracts with insurers. This creates a system with huge inconsistences on the prices of both generics and branded products.

Melissa A. Soliz, J.D., of Coppersmith Brockelman PLC is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In an interview with MHE, Soliz recommends the book, “The Immortal Life of Henrietta Lacks” by Rebecca Skloot to those in healthcare because "it is a compelling portrayal of how the law, ethics, ownership and business interests, and health inequities impact patient care and the advancement of that care from a generational perspective."

Sherry Rais, M.Sc., CEO and co-founder, Enthea, is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In an interview with MHE, she recommends "Nickel and Dimed: On (Not) Getting By in America" by Barbara Ehrenreich to not only those in healthcare, but all readers as the book illustrates the ways in which inequality affects people’s access to healthcare.

Hannah Ratcliffe, M.Sc., care model and quality lead at Waymark, a public benefit company using technology-enabled, community-based care to improve access and quality of care for people receiving Medicaid, is one of the 12 up-and-coming leaders in healthcare included in the annual Managed Healthcare Executive feature.

Sherry Rais, M.Sc., CEO and co-founder of Enthea, a licensed, third-party administrator of health insurance benefits with a mission to provide safe and affordable access to psychedelic-assisted psychotherapies, starting with ketamine therapy, is one of the 12 up-and-coming leaders in healthcare included in the annual Managed Healthcare Executive feature.

The week, the FDA approved Aphexda for use in stem cell mobilization. The agency also assigned action dates for resmetirom to treat patients with NASH and Libervant Film for young children and extended the review for lifileucel to treat melanoma. Additionally, an FDA advisory committee backed the use of Onpattro in cardiomyopathy of ATTR amyloidosis.

Jason Prestinario, M.S., CEO, Particle Health, which unlocks the power of medical records in an intelligent platform that puts the focus of health back on the patient, is one of the 12 up-and-coming leaders in healthcare included in the annual Managed Healthcare Executive feature.

In a JAMA Network Open study published Sept. 11, researchers wanted to take a deeper look into PrEP regimens’ impact on cardiometabolic health, as it is understudied. To do so they examined the risk of incident hypertension and statin use among adult health plan members starting PrEP with tenofovir alafenamide fumarate (TAF) compared adults taking tenofovir disoproxil fumarate (TDF).

Nora Lozano-Evjen of Equality Health, is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In an interview with MHE, Lozano-Evjen shared that after she moved to the United States from Mexico City, she became involved as a prevention specialist for two U.S. school districts, which introduced her to health and social disparities impacting underserved communities — especially those of color. The exposure to these realities pushed her toward the community health worker model she believes in today.

Nora Lozano-Evjen, community health worker manager at Equality Health, a value-based care leader focused on supporting independent primary care practices, is one of the 12 up-and-coming leaders in healthcare included in the annual Managed Healthcare Executive feature.